Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial.
published in: Clinical Cancer Research
date of publication: 2017-02-13
language: English
main subject: phase I clinical trial, immunotherapy
Cites articles 54
- 2015-04-01
- 2015-04-03
- 2014-01-31
- 2011-12-21
Date
Title
Article - wd:Q55642051